Skip to main content
. Author manuscript; available in PMC: 2018 Jan 24.
Published in final edited form as: Mol Imaging Biol. 2017 Oct;19(5):772–778. doi: 10.1007/s11307-017-1052-3

Figure 1. 123I-FP-CIT (DaTscan®) imaging alterations in PD compared to CG with SPM approach.

Figure 1

PD<CG contrast is presented (p<0.05 FDR whole-brain), showing the reduced DAT binding in basal ganglia bilaterally. Significant clusters were superimposed on a standardized MRI T1 3D template. Montreal Neurological Institute of standardized space are shown below of each slices. R: right. PD: Parkinson’s Disease. CG: control group. SPM: Statistical Parametric Mapping.